Publication:
Methods for meta-analyses of genome-wide association studies: Critical assessment of empirical evidence

dc.contributor.authorMartin Gögeleen_US
dc.contributor.authorCosetta Minellien_US
dc.contributor.authorAmmarin Thakkinstianen_US
dc.contributor.authorAlex Yurkiewichen_US
dc.contributor.authorCristian Pattaroen_US
dc.contributor.authorPeter P. Pramstalleren_US
dc.contributor.authorJulian Littleen_US
dc.contributor.authorJohn Attiaen_US
dc.contributor.authorJohn R. Thompsonen_US
dc.contributor.otherEURAC Researchen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Ottawa, Canadaen_US
dc.contributor.otherUniversity of Newcastle, Australiaen_US
dc.contributor.otherUniversity of Leicesteren_US
dc.date.accessioned2018-06-11T05:12:41Z
dc.date.available2018-06-11T05:12:41Z
dc.date.issued2012-04-15en_US
dc.description.abstractThere has been a steep increase in the number of meta-analyses of genome-wide association (GWA) studies aimed at identifying genetic variants with increasingly smaller effects, but pressure to publish findings of new genetic associations has limited the time available for careful consideration of all of their methodological aspects. The authors surveyed the literature (2007-2010) to provide empirical evidence on the methods used in GWA meta-analyses, including their organization, requirements about the uniformity of methods used in primary studies, methods for data pooling, investigation of between-study heterogeneity, and quality of reporting. This review showed that a great variety of methods are being used, but the rationale for their choice is often unclear. It also highlights how important methodological aspects have received insufficient attention, potentially leading to missed opportunities for improving gene discovery and characterization. Evaluation of power to replicate findings was inadequate, and the number of variants selected for replication was not associated with replication sample size. A low proportion of GWA meta-analyses investigated the presence and magnitude of heterogeneity, even when there was little uniformity in methods used in primary studies. More methodological work is required before clear guidance can be offered as to optimal methods or tradeoffs between alternative methods. However, there is a clear need for guidelines for reporting the results of GWA meta-analyses. © The Author 2012. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved.en_US
dc.identifier.citationAmerican Journal of Epidemiology. Vol.175, No.8 (2012), 739-749en_US
dc.identifier.doi10.1093/aje/kwr385en_US
dc.identifier.issn14766256en_US
dc.identifier.issn00029262en_US
dc.identifier.other2-s2.0-84859731474en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/14837
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859731474&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleMethods for meta-analyses of genome-wide association studies: Critical assessment of empirical evidenceen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859731474&origin=inwarden_US

Files

Collections